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Inability of mitochondria to generate energy leads to severe and often fatal
myoencephalopathies. Among these, Leigh syndrome (LS) is one of the most common
childhood mitochondrial diseases; it is characterized by hypotonia, failure to thrive,
respiratory insufficiency and progressive mental and motor dysfunction, leading to early
death. Basal ganglia nuclei, including the striatum, are affected in LS patients. However,
neither the identity of the affected cell types in the striatum nor their contribution
to the disease has been established. Here, we used a mouse model of LS lacking
Ndufs4, a mitochondrial complex I subunit, to confirm that loss of complex I, but not
complex II, alters respiration in the striatum. To assess the role of striatal dysfunction
in the pathology, we selectively inactivated Ndufs4 in the striatal medium spiny neurons
(MSNs), which account for over 95% of striatal neurons. Our results show that lack
of Ndufs4 in MSNs causes a non-fatal progressive motor impairment without affecting
the cognitive function of mice. Furthermore, no inflammatory responses or neuronal loss
were observed up to 6 months of age. Hence, complex I deficiency in MSNs contributes
to the motor deficits observed in LS, but not to the neural degeneration, suggesting that
other neuronal populations drive the plethora of clinical signs in LS.
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INTRODUCTION
Mutations in nuclear- or mitochondrial-encoded genes impairing energy metabolism lead
to mitochondrial disease, a heterogeneous group of severe, and often fatal, pathologies
affecting ∼1:5000 live births. Leigh Syndrome (LS, OMIM 256,000) is the most common
pediatric mitochondrial disease with a frequency of ∼1:40,000 live births (Rahman et al.,
1996), even though it is remarkably more common in some populations, ranging from
1:2000 up to 1:27 live births (Laberge et al., 2005; Finsterer and Zarrouk-Mahjoub, 2017).
Mutations in over 75 different genes have been described to cause LS (Lake et al., 2016).
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Currently there is no effective treatment or cure to LS, with most
therapeutic options being restricted to palliative approaches.
Although LS patients are highly heterogeneous clinically,
the common signs and symptoms comprise failure to thrive,
hypotonia, ataxia, lactic acidosis and encephalopathy (Finsterer,
2008a) that usually results in fatal respiratory failure at a young
age (Arii and Tanabe, 2000; Ferrari et al., 2017). MRI studies
on LS patients show the presence of characteristic symmetrical
bilateral lesions, usually in the basal ganglia or brainstem (Arii
and Tanabe, 2000). Even though these lesions have diagnostic
value, the relative contribution to the phenotype of the cell
type(s) affected by mitochondrial disease remains, for the most
part, unknown.
We have characterized a mouse model of LS that lacks
Ndufs4, a subunit of mitochondrial complex I. These animals
(Ndufs4 knockout, KO mice) recapitulate most of the clinical
features of human disease such as failure to thrive, hypotonia,
ataxia and fatal respiratory failure by about post-natal day 50
(Quintana et al., 2010, 2012b). Patients harboring mutations
in NDUFS4 present lesions in basal ganglia and/or brainstem
(Budde et al., 2003; Leshinsky-Silver et al., 2009). Accordingly,
Ndufs4 KO mice develop CNS lesions in the in late stages of
the disease, primarily in the brainstem and progressing to the
striatum, a key member of the basal ganglia (Quintana et al.,
2010; Quintana et al., 2012b). We have identified the role of
brainstem lesions in the fatal breathing alterations observed in
the Ndufs4 KO mice (Quintana et al., 2012b). However the
contribution of the striatum to the phenotype, has not been
determined.
The basal ganglia are a key relay in the motor system circuit
between the motor cortex and thalamus, and are implicated in
the control of motor coordination, voluntary movement, and
cue-dependent learning, among other functions (Gerfen, 1992;
Darvas and Palmiter, 2015). The striatum is a major component
in this circuitry, integrating and relaying cortical inputs to other
basal ganglia nuclei via GABAergic medium spiny neurons
(MSNs), which constitute over 95% of striatal neurons (Gerfen,
1992). Thus we hypothesized that striatal MSN dysfunction may
be responsible for the motor dysfunction observed in LS patients.
Here, we set out to establish the presence of primary striatal
complex I-mediated mitochondrial dysfunction in Ndufs4 KO
mice. Subsequently, to assess whether lack of Ndufs4 in MSN
is sufficient to elicit neurodegeneration and functional deficits
or if it rather requires the cross-talk between different cell-types
(Liu et al., 2015), we generated a mouse with conditional deletion
of Ndufs4 in striatal MSNs via Cre-mediated expression under
the control of Gpr88, a pan-MSN promoter (Quintana et al.,
2012a). We show that complex I deficiency in MSNs causes a
mild, progressive motor impairment in mice, in the absence of
inflammation or neuronal loss, and normal lifespan.
MATERIALS AND METHODS
Animals
Mice were housed in a facility with a 12-h light:dark cycle. All
animal experimentation was approved by the ethical committee
at University of Washington (IACUC), Seattle Children’s
Research Institute (IACUC), Universitat Autònoma de Barcelona
(CEEAH) and Generalitat de Catalunya (DMAH). Two groups
of animal lines were used in this study. To identify the presence
of primary striatal deficits after Ndufs4 deficiency, we used
animals lacking Ndufs4 constitutively (Ndufs4−/−, Ndufs4 KO)
mice and wild-type (WT) mice (Ndufs4+/+) as controls. These
mice were generated as described (Kruse et al., 2008; Quintana
et al., 2010). To achieve conditional deletion of Ndufs4 in
striatum, mice expressing cre recombinase under the control of
the Gpr88 promoter (Quintana et al., 2012a) and heterozygous
for Ndufs4 (Gpr88cre/+ ::Ndufs4∆/+) were bred with mice with
a floxed Ndufs4 alleles (Ndufs4lox/lox). GPR88 is selective of
striatal MSNs and does not target other cell types as striatal
interneurons or astrocytes (Quintana et al., 2012a). Out of
all the possible offspring, Gpr88cre/+ ::Ndufs4∆/lox mice have
loss of Ndufs4 selectively in MSNs (MSN KO mice). Mice
with Gpr88cre/+ ::Ndufs4lox/+ genotype with one functional
Ndufs4 allele were used as controls (MSN CTL mice).
Mitochondria Isolation
Mitochondria were isolated using Percoll density-gradient
centrifugation as described (Wang et al., 2011) with some
modifications. The striatum was dissected from the mouse brain
between postnatal day 42 or 43. Briefly, the brain tissue was
disrupted in 2 mL Isolation buffer A (IBA) using a 7-mL
glass Dounce homogenizer. The tissue was gently passed by
pestle A nine times and then pestle B eight times. The tissue
supernatant with 80% Percoll was layered over 15% Percoll
solution and then centrifuged at 16,200× g for 15 min at 4◦C.
1.5-mL sucrose washing buffer (WB) was used to re-suspend
the mitochondrial pellet. Following the final centrifugation, the
pellets were re-suspended with 50 µL of WB with no bovine
serum albumin (BSA) and combined into one tube. 1.5 mL of WB
was added. An additional centrifugation (10,000× g for 5 min
at 4◦C) was performed and the final mitochondrial pellet was
re-suspended in minimal (20 µL) WB with no BSA.
Oxygen Consumption (Seahorse Assay)
Mitochondrial oxygen consumption rate (OCR) was measured
over a 30-min time frame using the Seahorse Bioscience
XF24 extracellular flux analyzer following the manufacturer’s
instructions with some modifications (Johnson et al., 2013;
Kayser et al., 2016). Before the day of the assay, the cartridge
sensor was hydrated overnight with Seahorse Bioscience
XF24 Calibration buffer at 37◦C. On the day of the assay,
5 µg of mitochondria were added to assay media containing
500 mM malate and 500 mM pyruvate to assess complex I
activity; alternatively, 2 µg of mitochondria were added to
500 mM succinate, a complex II substrate, and 2 mM rotenone,
a complex I inhibitor. The two substrates independently
measured complex I and complex II respiration. Real-time
OCR (pmol/min/µg) was measured under basal condition and
in response to mitochondrial inhibitors. The final value was
corrected to account for protein loaded. Mitochondria were
exposed to sequential injections of 40 mM ADP, 25 µg/mL
oligomycin, 50 µM FCCP and 40 µg/µL antimycin A
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over 30 min. The final concentration of the inhibitors was
reduced 10-fold in the assay mix. ADP initiated state III,
oligomycin induced state IVo, FCCP induced an uncoupled
state and antimycin A induced complete electron transport
chain inhibition. Mitochondria isolated from Ndufs4 KO brain
tissue were compared to mitochondria isolated from a control
WT tissue. The study was performed in four replicates with
five technical replicates per condition. Technical replicates
within a single experiment were averaged.
Tissue Preparation
Mice were perfused with 4% paraformaldehyde (PFA) solution
to preserve their brain tissue. After 24 h in PFA, the brains
were cryopreserved in 30% sucrose PBS solution before freezing
with solid CO2. Then frozen brains were sliced into 30-µm
thick slices and suspended in a PBS solution in preparation for
histological analyses. For western blotting, brains were dissected
and snap-frozen in liquid nitrogen. Subsequently, samples were
homogenized in 1× RIPA buffer prepared with protease and
phosphatase inhibitors.
Immunofluorescence
Tissue slices were rinsed in a phosphate buffered saline with 0.2%
Tween (PBST) solution, non-specific binding was blocked with
a 10% normal donkey serum (NDS)/PBST solution for 60 min
at room temperature. Then tissue slices were incubated with
the primary antibodies: Iba 1 (1:1000, WAKO), GFAP (1:2000,
Sigma-Aldrich) in a 1% NDS/PBST solution overnight at 4◦C.
Subsequently, slices were again rinsed several times in PBST
before applying fluorochrome-conjugated secondary antibodies
(Jackson Immunoresearch) in a 1% NDS/PBST solution with
a 1:200 dilution for 60 min, effectively tagging any primary
antibodies bound to protein from the first staining with a
fluorescent label.
Western Blotting
Protein concentration was measured using the bicinchoninic
acid (BCA) method (Thermo Scientific). Subsequently, 20 µg
of cell lysate was denatured with sample buffer (62.5 mM
Tris–HCl pH6.8, 2% (v/v) SDS, 50 mM DTT, 10% (v/v) glycerol),
subjected to 4%–20% gradient SDS-PAGE, and transferred
onto nitrocellulose membranes (BioRad). The membranes were
blocked for 1 h with 5% (w/v) dried skimmed milk in TBS-T
buffer (25 mM Tris, 150 mM NaCl, and 0.1% (v/v) Tween-20,
pH 7.4), and incubated with the following primary antibodies:
mouse anti-GFAP (Sigma-Aldrich; 1:50,000), rabbit anti-Iba1
(Wako; 1:10,000), mouse anti-β-actin (Sigma-Aldrich; 1:20,000),
anti-NSE (1:1000, Dako), or anti-GAPDH (1:40000, GeneTex),
at 4◦C overnight. Then, membranes were incubated with
the corresponding HRP-coupled secondary antibodies (Jackson
Immunoresearch; 1:10,000) for 1 h at room temperature,
and the bands were visualized using the Super Signal West
Pico chemiluminescent substrate (Thermo Scientific). The
immunoreactive signals were quantified using ImageJ software
(National Institutes of Health, Bethesda, MD, USA). Iba1 and
GFAP values were normalized to β-ACTIN values. NSE results,
due to molecular weight, were normalized to GAPDH values.
Behavioral Testing
Locomotion
To assess relative activity levels of the mice, mice were
individually habituated for 48 h to the locomotion chambers
(Columbus Instruments). Then spontaneous locomotion was
assessed with ad libitum access to food and water for 48 h.
Distance traveled was calculated by Optomax Software as
described (Quintana et al., 2012a).
Motor Coordination
The rotarod was used to determine motor coordination and
learning as described (Quintana et al., 2010). Mice were placed on
an elevated accelerating rod (4–40 rpm in 4 min). Latency to fall
was recorded for three sessions, one session/day, each consisting
of three trials. Average values per session are shown.
Cue Learning
To asses cue learning, the water U-maze was employed (Quintana
et al., 2012a). The test was carried out in a metal U maze with
arms (50 cm, one black and one white) bent back toward the stem
(45 cm). An escape platform, not visible from the end of stem,
was present at the end of one of the two arms. Maze arms were
alternated in a non-repetitive, pseudo-random sequence daily (10
trials per day, 3–5-min inter-trial interval). The percentage of
correct trials was recorded. Mice remained in the maze until a
correct turn was made to ensure an equal number of reinforced
responses. An incorrect choice was recorded after a 20-s cutoff in
the stem or if the mouse entered the wrong arm at any time.
The strategy-shifting procedure consisted of two phases. For
phase 1, the mice had to learn a turn-based strategy for 3 days
with the escape platform always on the same side of the ramp.
For phase 2 (days 4–7), the platform was associated to the arm
color (cue-based strategy).
Statistics
Depending on the experimental design, Student’s T-test or
2-way analysis of variance (ANOVA) tests were performed using
Graphpad Prism software, p< 0.05 was considered as significant.
Data are shown as Mean± SEM.
RESULTS
Lack of Ndufs4 Impairs Striatal Complex
I-Mediated Respiration
Lesions in the striatum have been observed in humans
harboring NDUFS4 mutations (Budde et al., 2003) as well as
in Ndufs4 KO mice (Quintana et al., 2012b). However, the
existence of constitutive mitochondrial alterations in striata
of Ndufs4 KO mice had not been assessed. To identify
primary striatal mitochondrial defects, both complex I (CI)- and
complex II (CII)-dependent mitochondrial respiratory rates were
determined by performing extracellular flux analysis in purified
striatal mitochondrial preparations from Ndufs4 KO and control
mice (Figure 1). Striatal mitochondria from Ndufs4KO mice
presented reduced OCR after administration of the CI substrates
pyruvate and malate and ADP (state 3 respiration) and reduced
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FIGURE 1 | Complex I-mediated respiratory alterations in Ndufs4 knockout (KO) mice. (A) Complex I-dependent respiration (using pyruvate/malate as substrates)
and (B) complex II-mediated respiration (using succinate as substrate) in striata from Ndufs4 KO mice (n = 5) compared to wild-type (WT) mice (n = 5). Basal:
500 mM malate and 500 mM pyruvate (CI) or 500 mM succinate and 2 mM of the CI inhibitor rotenone (CII). ADP (40 mM) initiated state III, oligomycin (25 µg/mL)
induced state IVo, FCCP (50 µM) induced an uncoupled state and antimycin A (40 µg/µL) induced complete electron transport chain inhibition. ∗∗p < 0.01,
∗∗∗p < 0.001 vs. WT. Data are shown as mean ± SEM.
maximal respiratory capacity after administration of the ETC
uncoupler FCCP (Figure 1A). On the other hand, normal state
3 and maximal respiratory capacity OCR were obtained when
the CII substrate succinate together with CI-inhibitor rotenone
were provided (Figure 1B), suggesting a selective CI-mediated
dysfunction in the striata of Ndufs4KO.
Selective Ndufs4 Deletion in Striatal MSNs
Does Not Affect Lifespan or Body Weight
To assess the specific contribution of striatal deficiency to the
fatal phenotype observed in animals lacking Ndufs4 (Quintana
et al., 2010) we generated a new mouse line lacking Gpr88
expression in the striatum. To achieve this, we conditionally
ablated of Ndufs4 in striatum by driving selective Cre
recombinase expression under the Gpr88 promoter (Quintana
et al., 2012a) in animals with floxed Ndufs4 alleles (Quintana
et al., 2012b). Gpr88 expression is selectively expressed in
medium spiny neurons (Quintana et al., 2012a), which account
for over 95% of striatal neuronal population (Gerfen, 1992).
To minimize ectopic recombination during embryogenesis,
Cre-expressing male mice heterozygous for Ndufs4 gene were
crossed with females carrying two floxed Ndufs4 alleles. With this
strategy animals lacking striatal Ndufs4 expression (MSN KO)
and their controls (MSN CTL, heterozygous for Ndufs4) were
obtained (Figure 2A). MSN KO mice were born at the expected
Mendelian frequencies. No differences in lifespan or body weight
were observed in either male or female MSN KO mice compared
to their controls up to 6 months of age (Figure 2B). Western blot
analyses confirmed a selective decrease in NDUFS4 abundance in
the striata of MSN KO mice compared to controls (Figure 2C).
Progressive Locomotor Deficits after
Striatal MSN Ndufs4 Deletion
The striatum is a critical component of motor systems,
influencing movement through cortical and thalamic
connections (Alexander and Crutcher, 1990; Hoover and
Strick, 1993; Kravitz et al., 2010). To assess locomotor patterns
of MSN KO and control mice, their home-cage activity was
monitored for 48 h. At 2 months of age the activity of MSN
KO mice was the same as controls (Figures 3A,B). However,
when they were tested at 6 months of age, MSN KO mice
had significantly reduced locomotor activity on the second
night of the test, when animals are fully habituated to the new
environment (Figures 3C,D).
To assess motor coordination, MSN KO and MSN CTL mice
were tested monthly on an accelerating rod and their latencies
to fall were recorded (Figure 4A). MSN KO mice performed
the same as controls at 2 months of age, but their performance
progressively worsened between 3 and 6 months of age, revealing
a severe deficit in motor coordination and learning (Figure 4A).
Associative Learning Is Unaffected after
Loss of Ndufs4 in Striatal MSNs
Striatal function is necessary for associative learning (Packard
and Knowlton, 2002) and contributes to cognitive flexibility
processes (Darvas and Palmiter, 2009, 2011, 2015; Smith and
Graybiel, 2014) such as adapting to strategy shifting. Therefore,
we used a water-based, U-maze procedure (Quintana et al.,
2012a) to test the ability of 6-month-old mice to identify
the correct strategy to find an escape platform at the end
of one of the maze arms. During the first 3 days, mice
were trained daily to learn a turn-based strategy. In this
paradigm, both MSN KO and control mice presented a similar
percentage of correct choices and learning rate (Figure 4B).
Subsequently, mice were forced to shift to a cue-based strategy,
by associating the platform to the color of the arms, for five
daily sessions. After the shift, there was a decrease in the
number of correct choices, improving with further training.
However, no differences between genotypes were observed
(Figure 4B).
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FIGURE 2 | Generation of a mouse line lacking Ndufs4 in the striatal medium spiny neurons (MSNs). (A) Breeding strategy to generate animals with conditional
Ndufs4 deletion in striatal MSNs (MSN KO) and their genetic controls (MSN CTL). (B) Body weight curves for MSN KO mice (n = 5 males, n = 6 females) and MSN
CTL (n = 14 males, n = 11 females). (C) Representative western blot analyses of total Ndufs4 and β-Actin (loading control) in the striatum and brainstem of MSN KO
and CTL mice (n = 3). Data are shown as mean ± SEM.
FIGURE 3 | Reduced activity in MSN KO mice. Spontaneous activity was recorded for 48 h. Activity pattern (A) and quantification of nocturnal activity (B) of
2-month-old MSN KO (n = 6) and MSN CTL mice (n = 6). (C) Activity pattern and (D) quantification of nocturnal activity of 6-month-old MSN CTL (n = 7) and MSN
KO mice (n = 8); ∗∗p < 0.01. Data are shown as mean ± SEM.
Loss of Ndufs4 in Striatal MSNs Does Not
Induce Reactive Gliosis or Neuronal Loss
Reactive gliosis is one of the hallmarks of LS (Finsterer,
2008a). To assess the presence of astroglial and microglial in
MSN KO mice we performed immunofluorescence labeling
against GFAP and Iba-1, respectively, in striata of 6-month-old
MSN KO and control mice. Morphologically, both genotypes
presented non-hypertrophic astrocytes and ramified microglial
cells, suggestive of a nonreactive status (Raivich et al., 1999;
Figure 5A). Total abundance of GFAP and Iba1 was not different
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FIGURE 4 | Motor alterations but intact associative learning in MSN KO mice. (A) Rotarod performance of MSN KO mice (n = 13) and MSN CTL mice (n = 26).
(B) Water U-maze performance of 6-month-old MSN KO mice (n = 7) and MSN CTL mice (n = 8). Animals were trained for 3 days on a turn-based escape procedure
and subsequently forced to change to a cue-based escape strategy. ∗∗∗p < 0.001 vs. Ndufs4cCTGpr88. Data are shown as mean ± SEM.
FIGURE 5 | Lack of reactive gliosis in the striatum or neuronal loss after Ndufs4 ablation in MSNs. (A) Representative GFAP (red) and Iba1 (green)
immunofluorescence in striatum (Str) of MSN KO and MSN CTL mice. cc: corpus callosum. lv: lateral ventricle. (B,C) Representative western blot analyses of GFAP,
Iba1, NSE and β-actin and GAPDH (loading controls) and quantification (C) in the striatum and brainstem of MSN KO and MSN CTL mice (n = 3–9). Data are shown
as mean ± SEM.
in the striata of MSN KO and control mice as assessed by Western
Blot (Figures 5B,C).
To assess neuronal loss, neuron specific enolase (NSE) levels
were quantified (Scarna et al., 1982; Ding et al., 2000). Total
striatal NSE abundance was not altered in the striata of MSN
KO mice compared to MSN control as assessed by Western Blot
(Figures 5B,C).
DISCUSSION
One of the main clinical hallmarks of LS is the presence
of symmetrical brain lesions, typically in the brainstem
or in the basal ganglia (Rahman et al., 1996; Arii and
Tanabe, 2000; Finsterer, 2008a). While brainstem affectation
is overtly evident in Ndufs4 KO mice, basal ganglia are
relatively spared histopathologically in these mice (Quintana
et al., 2010). However, our previous work reveals lesions
in the striatum in Ndufs4 KO mice in which brainstem
lesions were suppressed (Quintana et al., 2012b). Hence,
we decided to explore the contribution of selective striatal
mitochondrial dysfunction to the phenotype of these
mice.
In this study, we identify the existence of an intrinsic deficit in
Complex I-mediated mitochondrial respiration in the striata of
Ndufs4 KO mice, suggesting that progressive impairment in this
area may be conducive to the appearance of lesions. Impairment
in CI-mediated mitochondrial respiration had been reported
in different tissues both in human patients and mice lacking
functional NDUFS4 expression (Budde et al., 2003; Kruse et al.,
2008; Leong et al., 2012; Kayser et al., 2016; Ortigoza-Escobar
et al., 2016). A recent report has shown region-specific alterations
in the respiratory capacities of Ndufs4 KO mice (Kayser et al.,
2016), correlating with the histopathological features. Hence, it is
likely that the delay in appearance of striatal lesions is the result
of a milder impairment in respiratory capacity.
To assess the specific role of striatal mitochondrial
CI-dysfunction, we conditionally ablated Ndufs4 in medium
spiny neurons (MSN KO mice). Accordingly, striatal
NDUFS4 levels were markedly reduced in in these mice.
However, this reduction was not associated with reduced body
weight or premature death, hallmarks of the disease in mice
lacking NDUFS4 protein in all cells or just in the central nervous
system (Kruse et al., 2008; Quintana et al., 2010) or LS patients
(Rahman et al., 1996; Finsterer, 2008a), suggesting that these
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clinical signs are not mediated by MSN dysfunction. In this
regard, we had previously shown that Ndufs4 KO mice presented
lesions in the brainstem, associated with breathing alterations
and death (Quintana et al., 2010, 2012b). Accordingly, brainstem
lesions have been associated with central respiratory deficits and
poor prognosis in human patients (Arii and Tanabe, 2000).
Behaviorally, MSN KO mice presented a progressive motor
impairment, with reduced spontaneous locomotion and
worsening of motor coordination as assessed by the rotarod
test. Loss of already acquired psychomotor skills (as observed in
the rotarod test) is one of the first clinical signs of LS patients
(Rahman et al., 1996; Finsterer, 2008a). The striatum plays
a pivotal role in movement control by integrating cortical,
thalamic and dopaminergic inputs (Alexander and Crutcher,
1990; Gerfen, 1992; Hoover and Strick, 1993). MSNs, the only
projection neurons in the striatum, consist of two different
subpopulations (defined by the expression of either dopamine
D1 or D2 receptors) that modulate movement by two opposing
output pathways, the striatonigral and the striatopallidal,
respectively (Gerfen, 1992; Kravitz et al., 2010; Lanciego et al.,
2012). In this study Cre recombinase was driven by the Gpr88
promoter, which expressed all MSNs but does not target striatal
interneurons or astrocytes (Quintana et al., 2012a). Hence, our
results suggest that striatal mitochondrial dysfunction in MSNs
is sufficient to recapitulate the motor deficits of the human
disease.
Cognitive impairment is frequently observed in LS patients
(Finsterer, 2008b). Cortico-striatal basal ganglia pathways are
necessary to properly perform several cognitive tasks (Quintana
et al., 2012a; Darvas and Palmiter, 2015). However, MSN
KO mice performed as well as controls in the U-maze test,
suggesting that mitochondrial dysfunction in MSNs is not
sufficient to impair associative learning or cognitive flexibility.
It is likely that other brain areas, such as cortex, compensate for
striatal deficits. Alternatively, MSN function may be sufficiently
maintained to allow for correct striatal processing of cognitive
processes.
We did not detect any signs of reactive gliosis, as assessed
by immunofluorescence and western blot analyses for astrocyte
(GFAP) or microglial (IBA1) markers. Accordingly, it has
recently been described that mitochondrial dysfunction in
Ndufs4 KO mice is present even in brain areas not associated
to inflammation and histological alterations (Kayser et al., 2016).
Furthermore, no neuronal loss was observed in MSN KO up to
6 months of age, in contrast to our previous results (Quintana
et al., 2010, 2012b). These results may suggest that a striatal cell
population other than MSNs contributes to the appearance of
inflammation and neuronal loss. Alternatively, they may result
from defects in brain regions that project axons to the striatum.
In this regard, it has been described that axonal degeneration may
lead to inflammation and lesion formation in the terminal fields
(Coleman, 2005).
A key remaining aspect is identifying the mechanism
underlying the loss of motor function without overt
inflammation of neurodegeneration. Several possibilities
may explain these findings. First, while NSE determination
has been used an indirect correlate of neurodegeneration
(Scarna et al., 1982; Ding et al., 2000) it does not possess
the resolution and the sensitivity of stereological cell
counts to detect neuronal loss. Further studies aimed at a
detailed histological characterization of MSN KO striata are
warranted. Second, the fact that MSN KO are heterozygous for
Ndufs4 in all cell types not expressing Cre recombinase may
initiate compensatory mechanisms leading to mitochondrial
preconditioning, which has been proven neuroprotective
in several paradigms (Correia et al., 2010). Along the same
lines, another possibility is that neurodegeneration may be
the result of a complex cross-talk between cell-types rather
than a cell-autonomous mechanism. Our previous results have
pointed to the requirement of neuronal-astrocyte cross-talk
to elicit neurodegeneration in Ndufs4KO mice (Liu et al.,
2015). However, in MSN KO mice astrocytic mitochondrial
function is likely spared. Finally, a recent study shows that
Ndufs4 deletion in dopaminergic neurons causes Parkinson’s
disease-like non-motor symptoms without neuronal loss, likely
due to reduced dopamine brain levels (Choi et al., 2017).
Hence, it is feasible that even though not sufficient to elicit
neurodegeneration, lack of Ndufs4 may alter MSN function
leading to behavioral deficits. Further studies will be directed
at characterizing in more detail MSN physiology after Ndufs4
ablation.
In conclusion, we have identified that Ndufs4 deficiency
leads to a reduction in the respiratory capacity in the striatum.
Furthermore, specific deletion of this gene in MSNs leads
to a progressive motor impairment, with absence of overt
reactive gliosis, inflammation or neuronal loss. These results
underscore the contribution of basal ganglia alterations to
the motor phenotype observed in LS. Currently, there is no
effective treatment for LS, although several potential therapies
have been proposed (Johnson et al., 2013; Jain et al., 2016;
Ferrari et al., 2017). Future investigations are needed to establish
the relative contribution of susceptible brain regions to the
pathology, which may help identify the therapeutic potential of
new treatments.
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